Me could be back in the hands of former CEO Anne Wojcicki after her nonprofit offered $305 million to buy the company.

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron ...

AI data centers need energy, and that’s what’s made the stock price of aptly-named NRG $NRG rise 88% in the past year ...

House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer ...

The consumer privacy ombudsman tasked with analyzing the impact of 23andMe’s bankruptcy sale on individuals’ privacy has ...

Also this week, more than two dozen states sued 23andMe to challenge the sale of its customers’ private data. The states argue the company must obtain explicit consent from its ...

Most of the password managers I’ve tested include some form of dark web monitoring or scanning in the password health section ...

A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety ...

Twenty seven states, including Pennsylvania, Michigan and Florida, and the District of Columbia filed the lawsuit on Monday ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) 46th Annual Goldman Sachs Global Healthcare Conference June 9, 2025 10:40 AM ETCompany ...